Literature DB >> 17852839

Incidence rates and causes of cirrhosis in a Norwegian population.

John W Haukeland1, Inger Lorgen, Linn Therese Schreiner, Svein-Oskar Frigstad, Bjørn Brandsaeter, Kristian Bjøro, Christina Bang, Nils Raknerud, Zbigniew Konopski.   

Abstract

OBJECTIVE: To investigate the incidence rate and causes of cirrhosis in a Norwegian population. We also sought to assess the degree of underreporting of cirrhosis to the Norwegian Death Registry.
MATERIAL AND METHODS: All 1264 patients treated at Aker University Hospital in the period January 1999 to March 2004 who were given a diagnosis indicating cirrhosis, chronic liver disease or symptoms possibly attributable to cirrhosis were screened retrospectively. A search in the registry of histological diagnoses at Department of Pathology was also carried out. Based on the results of histological examinations and non-histological criteria, cirrhosis was confirmed in 194 patients. Calculations of the incidence rate of cirrhosis and frequencies of the various etiologies were based on 93 patients living in the catchment area of the hospital. Causes of death were retrieved from the Norwegian Death Registry.
RESULTS: The incidence rate of cirrhosis was 134 per million per year. The majority of cases were due to alcoholic liver disease (53%), followed by viral liver disease (12%), various autoimmune liver diseases (12%), hemochromatosis (4%) and non-alcoholic steatohepatitis (NASH) (3%). No etiology was established in 16%, a group with a high prevalence of diabetes mellitus, indicating that some of these cases were possibly caused by NASH. Among 105 deaths in this cohort of 194 cirrhotic patients, the diagnosis of cirrhosis was absent in the Norwegian Death Registry in 30% of cases.
CONCLUSIONS: The incidence of cirrhosis in Norway is relatively low, with alcohol as the most important etiologic factor. Significant underreporting to the Norwegian Death Registry was observed.

Entities:  

Mesh:

Year:  2007        PMID: 17852839     DOI: 10.1080/00365520701478014

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  9 in total

1.  Chemoembolization of intermediate stage hepatocellular carcinomas: results from a Nordic tertiary liver cancer center.

Authors:  Kasper J Andersen; Henning Grønbaek; Gerda Elisabeth Villadsen; Anders Riegels Knudsen; Peter Ott; Hendrik Vildstrup; Dennis Tønner Nielsen; Arindam Bharadwaz
Journal:  Indian J Gastroenterol       Date:  2013-12-04

2.  Changing trends of hospitalisation of liver cirrhosis in Beijing, China.

Authors:  Xiao-Yuan Bao; Bei-Bei Xu; Kai Fang; Yan Li; Yong-Hua Hu; Guo-Pei Yu
Journal:  BMJ Open Gastroenterol       Date:  2015-08-27

3.  Health and economic benefits of reducing sugar intake in the USA, including effects via non-alcoholic fatty liver disease: a microsimulation model.

Authors:  Rick A Vreman; Alex J Goodell; Luis A Rodriguez; Travis C Porco; Robert H Lustig; James G Kahn
Journal:  BMJ Open       Date:  2017-08-03       Impact factor: 2.692

4.  Changes in Etiologies of Hospitalized Patients with Liver Cirrhosis in Beijing 302 Hospital from 2002 to 2013.

Authors:  Binxia Chang; Baosen Li; Ying Sun; Guangju Teng; Ang Huang; Jin Li; Zhengsheng Zou
Journal:  Mediators Inflamm       Date:  2017-11-19       Impact factor: 4.711

5.  Modelling the burden of hepatitis C infection among people who inject drugs in Norway, 1973-2030.

Authors:  Hinta Meijerink; Richard A White; Astrid Løvlie; Birgitte Freiesleben de Blasio; Olav Dalgard; Ellen J Amundsen; Espen Melum; Hilde Kløvstad
Journal:  BMC Infect Dis       Date:  2017-08-03       Impact factor: 3.090

6.  Periodontitis in patients with cirrhosis: a cross-sectional study.

Authors:  Lea Ladegaard Grønkjær; Palle Holmstrup; Søren Schou; Johanne Kongstad; Peter Jepsen; Hendrik Vilstrup
Journal:  BMC Oral Health       Date:  2018-02-13       Impact factor: 2.757

7.  Effect of gender on mortality and causes of death in cirrhotic patients with gastroesophageal varices. A retrospective study in Norway.

Authors:  John Willy Haukeland; Milada Cvancarova Småstuen; Pia Pernille Pålsdatter; Moonisah Ismail; Zbigniew Konopski; Kristin Kaasen Jørgensen; Hans Lannerstedt; Håvard Midgard
Journal:  PLoS One       Date:  2020-03-12       Impact factor: 3.240

8.  Incidence, aetiology and related comorbidities of cirrhosis: a Swedish population-based cohort study.

Authors:  Juan Vaz; Berne Eriksson; Ulf Strömberg; David Buchebner; Patrik Midlöv
Journal:  BMC Gastroenterol       Date:  2020-04-03       Impact factor: 3.067

9.  A nationwide population-based prospective study of cirrhosis in Iceland.

Authors:  Sigurdur Olafsson; Sigurjon Rögnvaldsson; Ottar M Bergmann; Jon G Jonasson; Ubaldo Benitez Hernandez; Einar S Björnsson
Journal:  JHEP Rep       Date:  2021-03-31
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.